Drug Trial Radar · NCT03395392
NRX-101 for Bipolar Depression With Subacute Suicidal Ideation
Last checked: Nov 19, 2026Latest source record: May 8, 2024 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
74
Actual
Start
May 12, 2022
Primary completion
Feb 28, 2024
Study completion Mar 30, 2024
Sponsor
- Lead sponsor
- NeuroRx, Inc.Industry
- Sponsor type
- Industry
- Collaborators
- Prevail Infoworks
- First posted
- Jan 10, 2018
Design
- Study type
- Interventional
- Phase
- Phase 2 / Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 65 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
NMDA antagonist drugs have shown to reduce symptoms of depression and suicidal ideation. NeuroRx has developed NRX-101 (fixed dose combination of D-cycloserine and lurasidone) for oral use in the treatment of bipolar depression with suicidal ideation. This study will test the hypothesis that NRX-101 is superior to lurasidone alone (standard of care) in maintaining remission from symptoms of depression (primary endpoint) and suicidal ideation or behavior (declared secondary endpoint) over a six week period of twice-daily oral dosing.
Conditions
- Bipolar Depression
- Suicidal Ideation and Behavior
Interventions
NRX-101Drug
NRX-101, a fixed dose combination of D-cycloserine+lurasidone will be given twice a day by mouth
Lurasidone HClDrug
Lurasidone HCl will be given twice a day by mouth
Primary outcomes
What the sponsor says the trial is designed to measure.
- Change from Baseline in MADRS-10 over 42 DaysTime frame: Six weeks
Locations
14 sites in 1 country. Site status is shown where the registry gives one.
Science 37
Culver City, California
San Marcus Research Clinic, Inc.
Miami Lakes, Florida
ACMR
Atlanta, Georgia
iResearch Atlanta, LLC
Decatur, Georgia
iResearch Savannah
Savannah, Georgia
CBH Health
Gaithersburg, Maryland
Omaha Insomnia and Psychiatric Services
Omaha, Nebraska
Dent Neurologic Institute
Amherst, New York
Peace Health Medical Group
Eugene, Oregon
University of Texas Health Austin
Austin, Texas
Roots Behavioral Health
Austin, Texas
JPS Health
Fort Worth, Texas
Houston Mind and Brain
Houston, Texas
Health Texas
Richmond, Texas
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.